AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Dec 20, 2018
30071_dirs_2018-12-20_1e00fc9e-166d-46c2-b928-e7d6279194e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-12-18
Reporting Person: Sodhi Rajwant (President, SaaS Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-18 | ResMed Common Stock | F | 67 | $106.94 | Disposed | 42541 | Direct |
| 2018-12-18 | ResMed Common Stock | F | 77 | $106.94 | Disposed | 42464 | Direct |
| 2018-12-18 | ResMed Common Stock | F | 86 | $106.94 | Disposed | 42378 | Direct |
Footnotes
F1: Disposition to issuer for corrected tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.
F2: Disposition to issuer for corrected tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.
F3: Disposition to issuer for corrected tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29